BIONURE FARMA, S.L.;INSTITUT D'INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER (IDIBAPS) (undivided 30% interest);CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS (CSIC) (undivided 20% interest)
发明人:
Pablo Villoslada,Angel Messeguer
申请号：
US15261410
公开号：
US10106577B2
申请日:
2016.09.09
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The invention relates to compounds of Formula I:and pharmaceutically acceptable salts and prodrugs thereof, wherein R1, R2, and R3 are defined as set forth in the specification. The compounds are agonists of neurotrophin (such as nerve growth factor) receptors.
